Evoke Pharma (EVOK) Financials

$11.00

$0.00 (0.00%)

As on 17-Dec-2025 09:30EDT

Market cap

$19 Mln

Revenue (TTM)

$14 Mln

P/E Ratio

--

P/B Ratio

5.6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	14.42	10.25	5.18	2.51	1.62	0.02
Cost of Revenue	0.43	0.36	0.20	0.37	0.33	0.09
Gross Profit	13.99	9.89	4.98	2.14	1.29	-0.06
Operating Expenses	19.19	15.10	12.41	9.92	9.44	12.98
Operating Profit (EBIT)	-5.19	-5.20	-7.43	-7.79	-8.15	-13.05
Other Income	--	--	--	--	--	--
Profit before Tax	-5.23	-5.35	-7.79	-8.22	-8.54	-13.15
Provision for Tax	2.72	--	-7.43	-0.06	0.49	0.11
Profit after Tax (Net Income)	-5.23	-5.35	-7.79	-8.22	-8.54	-13.15
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-8.22	-8.54	-13.15

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	3.36	7.04	-2.58	4.08	3.56	-3.21
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.05	0.10	6.61	6.11	5.61	5.11
Current Liabilities	12.24	10.38	9.65	1.65	1.41	7.54
Total Liabilities	27.89	17.52	7.07	11.85	10.57	9.43

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	0.11	0.28	0.24	0.13	0.01	0.15
Current Assets	15.54	17.24	6.83	11.72	10.56	9.28
Total Assets	27.89	17.52	7.07	11.85	10.57	9.43
Total Debt*	5.11	5.16	10.00	5.13	5.01	5.25
Net Current Assets	3.30	6.86	3.79	10.07	9.15	1.75

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-5.46	-4.98	-6.60	-12.35	-6.63
Cash Flow from Investing Activities	--	--	--	--	--	--
Cash from Financing Activities	--	14.32	-0.12	7.29	13.43	9.04
Net Cash Inflow / Outflow	--	--	--	--	--	2.41

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-2.38	-3.60	-2.33	-29.52	-37.65	-71.14
Cash EPS ($)	--	-3.60	-2.33	-29.52	-37.65	-71.14
Adjusted Book Value ($)	--	4.74	--	14.66	15.68	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-3.67	-1.49	-23.68	-54.47	-35.86
Free Cash Flow per Share ($)	--	-3.67	-1.49	-23.68	-54.47	-35.86

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-54.56	-93.69	-92.50	-161.11	-401.65
ROE (%)	-113.57	-240.09	-1,035.44	-215.30	-5,015.38	-2,256.53
ROA (%)	-20.17	-43.54	-82.37	-73.35	-85.35	-166.20
EBIT Margin (%)	-7.65	-47.33	-140.76	-307.90	-496.76	-56,653.68
Net Margin (%)	-36.23	-52.22	-150.41	-327.83	-527.66	-57,144.53
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	67.40	0.98	1.07	0.55	69.29	--
EBIT Growth (%)	88.12	33.48	5.59	3.90	38.37	-82.29
Net Profit Growth (%)	14.98	31.31	5.25	3.68	35.10	-85.36
EPS Growth (%)	47.62	-0.55	0.92	0.22	0.47	-0.69
Book Value Growth (%)	-58.05	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-1.23	-0.45	-0.09	-0.01	-0.04
Price / Book Value	5.64	0.93	-1.36	0.18	0.04	-0.15
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.36	-38,483,124.80	-1.23	0.51	0.50	0.18
Close Price ($)	4.97	4.42	12.60	32.16	79.20	371.52
High Price ($)	12.32	13.80	71.52	201.60	691.20	873.04
Low Price ($)	1.94	3.54	11.02	16.46	73.15	113.76
Market Cap ($ Cr)	18.95	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	0.73	-3.88	1.26	1.41	-1.63
Short term debt to equity ratio	1.51	0.72	-1.94	0.03	0.00	-0.08
Current Ratio	1.27	1.66	0.71	7.08	7.51	1.23
Quick Ratio	1.22	1.62	0.66	6.91	7.38	1.20
Interest Coverage	-9.45	-9.68	-14.58	-15.45	-16.07	-115.42

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	22.12	23.61	12.99	24.91	18.24	101.26
Asset Turnover	0.56	0.83	0.55	0.22	0.16	0.00
Receivable days	--	55.12	45.75	66.98	35.95	369.87
Inventory Days	--	474.79	697.66	234.16	234.89	996.11
Payable days	--	1,922.37	2,334.02	859.07	1,195.32	4,858.70
Cash Conversion Cycle	--	-1,392.46	-1,590.60	-557.94	-924.48	-3,492.73

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.